Trial reportActa neuropsychiatrica2014
Protocol to evaluate the impact of yoga supplementation on cognitive function in schizophrenia: a randomised controlled trial.
Trial report in Acta neuropsychiatrica, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 4 syntheses or guidelines pooled it, 16 citations in OpenAlex.
- Yoga as part of a package of care versus non-standard care for schizophrenia.The Cochrane database of systematic reviews · 2019Pooled it
- Yoga as part of a package of care versus standard care for schizophrenia.The Cochrane database of systematic reviews · 2017Pooled it
- Yoga versus non-standard care for schizophrenia.The Cochrane database of systematic reviews · 2017Pooled it
- Yoga versus standard care for schizophrenia.The Cochrane database of systematic reviews · 2015Pooled it
- Feasibility, acceptability and evaluation of meditation to augment yoga practice among persons diagnosed with schizophrenia.Acta neuropsychiatrica · 2022Trial
- Adjunctive yoga training for persons with schizophrenia: who benefits?Acta neuropsychiatrica · 2021Trial
- A randomised controlled trial of adjunctive yoga and adjunctive physical exercise training for cognitive dysfunction in schizophrenia.Acta neuropsychiatrica · 2017Trial
- Knowledge, behavior, and effect of health messaging during the first Indian lockdown for COVID-19.Industrial psychiatry journal · 2024Article
- Evidence and gap map of studies assessing the effectiveness of interventions for people with disabilities in low-and middle-income countries.Campbell systematic reviews · 2020Article
- Cognitive remediation in schizophrenia-The view from India.Asian journal of psychiatry · 2016Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 2 countries.
Funding
Abstract
backgroundSchizophrenia (SZ) is a chronic illness that is treated symptomatically. Cognitive dysfunction is a core feature of SZ that is relatively intractable to pharmacotherapy. Yoga can improve cognitive function among healthy individuals. A recent open trial indicated significant benefits of yoga training (YT) in conjunction with conventional pharmacotherapy among patients with SZ.
aimsTo describe the protocol for an ongoing randomised controlled trial designed to test whether the reported beneficial effects of YT on cognitive function among SZ patients can be replicated. Secondarily, the effects of YT on daily functioning living skills are evaluated.
methodsConsenting patients with SZ receive routine clinical treatment and are randomised to adjunctive YT, adjunctive physical exercise (PE) or treatment as usual (proposed N = 234 total, N = 78 in each group). The trial involves YT or PE 5 days a week and lasts 3 weeks. Participants are evaluated thrice over 6 months. Cognitive functions measured by Trail Making Test, University of Pennsylvania Neurocognitive Computerised Battery were primary outcome measures while clinical severity and daily functioning measured by Independent Living Skills Survey were secondary outcome measures.
resultsA total of 309 participants have been randomised as of 31 August 2013, which exceeded beyond 294 proposed after attrition. Once participants begin YT or PE they generally complete the protocol. No injuries have been reported.
conclusionsShort term YT is feasible and acceptable to Indian SZ patients. If beneficial effects of YT are detected, it will provide a novel adjunctive cognitive remediation strategy for SZ patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.